Ascendis Pharma A/S said underwriters of its offering of American depositary shares fully exercised the option to buy 570,000 ADSs.

On Oct. 5 the company closed the sale and issuance of the ADSs pursuant to the underwriting agreement.

The agreement was signed among the company and J.P. Morgan Securities LLC, Merrill Lynch, Pierce Fenner & Smith Inc. and Credit Suisse Securities (USA) LLC as representatives of several underwriters.